Obesity and Left Ventricular Dilatation in Young Adulthood: The Bogalusa Heart Study

Abstract

Abstract Background: Cardiac enlargement is an important predictor of adverse cardiovascular (CV) events. Left ventricular (LV) dilatation is a precursor both of LV dysfunction and clinical heart failure. The present study examines risk factors for LV dilatation among 832 young adults (341 male, 491 female) who participated in the Bogalusa Heart Study. Hypothesis: A unique set of risk factors predicts LV dilatation among young adults. Methods: Standard ventricular dimensions were determined by M‐mode echocardiography and indexed to height using a standard method. LV dilatation was considered as the top 20th percentile of LV end‐diastolic dimension indexed to height. Logistic regression models were used, stratified by race and sex, to assess the relationship of CV risk factors with quintile of LV end‐diastolic dimension indexed to height. Results: The mean age (standard deviation) of men and women in the population was 36.4 years (3.9 years) and 35.9 years (4.6 years), respectively. In sex‐specific models adjusted for age, race, systolic and diastolic blood pressure, high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol, triglycerides, and glycosylated hemoglobin, body mass index (BMI) was a significant predictor of LV dilatation in both men and women. The odds ratio (95% confidence interval) for a 1‐unit change in BMI was 1.12 (1.02–1.19) in men and 1.09 (1.05–1.13) in women. Among men, triglyceride level was also significantly associated with LV dilatation ( P = 0.03), whereas among women there was no such association. Conclusions: Our findings indicate that obesity is the most consistent predictor of LV dilatation in both men and women, whereas triglyceride level was a significant predictor among men only. © 2011 Wiley Periodicals, Inc. The Bogalusa Heart Study is supported by a grant from the National Institute of Aging (5R01AG016592). Dr. Bazzano was supported by grant no. K08HL091108 from the National Heart Lung and Blood Institute (NHLBI). The authors have no other funding, financial relationships, or conflicts of interest to disclose.